 previous article in this issue | next article in this issue  |
|
Document Details : Title: Gamma-glutamyl transferase predicts recurrences of atrial fibrillation after catheter ablation Author(s): F.M. Uçar , E. Gucuk İpek , B. Acar , M. Gul , A. Tunçez , Ö. Özeke , B. Geyik , S. Topaloglu , D. Aras Journal: Acta Cardiologica Volume: 71 Issue: 2 Date: 2016 Pages: 205-210 DOI: 10.2143/AC.71.2.3141851 Abstract : Background: Catheter ablation is a popular therapy of atrial fibrillation (AF). Gamma-glutamyl transferase (GGT) is known as a marker of oxidative stress. The objective of this study was to ascertain the relationship between levels of GGT and recurrence of AF after catheter ablation. Methods: A total of 102 paroxysmal AF patients who underwent cryoballoon catheter ablation were enrolled. Serum samples were obtained to evaluate GGT levels before catheter ablation. Cox regression analysis was used to estimate the predictors of AF recurrence. Results: Mean age of the cohort was 49.9 ± 11.7 and 63% of the patients were male. After a mean follow-up of 20 months, 19 (23%) patients had AF recurrences. The baseline GGT levels were significantly higher in patients who had AF recurrence [27 U/L (17-36) vs 18 U/L (13-22), P = 0.002]. The optimal cut-off value of GGT to predict AF recurrence was 23.5 U/L according to receiver operating characteristic curve analysis (area under the curve 0.72, P = 0.002). In the multivariable Cox regression analysis, baseline GGT > 23.5 was the only independent predictor of AF recurrence (hazard ratio (HR) 4.47, 95% confidence interval [1.66-12.09], P = 0.003). Conclusions: Our results indicate that elevated GGT is associated with AF recurrence. A simple measurement of GGT may help us to identify high-risk patients undergoing catheter ablation for AF. |
